Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-14 influenza season

[tetano]

Clin Infect Dis. 2015 Feb 25. pii: civ146. [Epub ahead of print]
[h=1]Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-14 influenza season.[/h] Havers FP[SUP]1[/SUP], Flannery B[SUP]1[/SUP], Clippard JR[SUP]1[/SUP], Gaglani M[SUP]2[/SUP], Zimmerman RK[SUP]3[/SUP], Jackson LA[SUP]4[/SUP], Petrie JG[SUP]5[/SUP], McLean HQ[SUP]6[/SUP], Nowalk MP[SUP]3[/SUP], Jackson ML[SUP]4[/SUP], Monto AS[SUP]5[/SUP], Belongia EA[SUP]6[/SUP], Eng HF[SUP]7[/SUP], Lamerato L[SUP]8[/SUP], Campbell AP[SUP]1[/SUP], Fry AM[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] During the 2013-14 influenza season, we analyzed data from 6,004 outpatients aged ≥6 months with acute respiratory illness (ARI). Among the 2,786 ARI patients at higher risk for influenza complications, 835 (30%) presented to care ≤2 days from symptom onset; among those, 126 (15%) were prescribed an antiviral medication.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.


PMID: 25722198 [PubMed - as supplied by publisher]